Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

JERUSALEM PHARMACEUTICALS CO. LTD.

(JPH)
  Report
End-of-day quote PALESTINE SECURITIES EXCHANGE  -  2022-11-29
3.450 USD   -1.43%
11/10Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
08/15Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
05/15Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
SummaryQuotesChartsNewsCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021

03/31/2022 EST

Jerusalem Pharmaceuticals Co. Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was USD 46.23 million compared to USD 36.4 million a year ago.

Net income was USD 6.6 million compared to USD 3.73 million a year ago. Basic earnings per share from continuing operations was USD 0.367 compared to USD 0.207 a year ago.


ę S&P Capital IQ 2022
All news about JERUSALEM PHARMACEUTICALS CO. LTD.
11/10Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and N..
CI
08/15Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and ..
CI
05/15Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the First Quarter Ended..
CI
03/31Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended Dec..
CI
2021Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and N..
CI
2021Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter Ende..
CI
2021Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended Dec..
CI
2019Jerusalem Pharmaceuticals Co. Ltd. Announces Unaudited Consolidated Earnings Results fo..
CI
2019Jerusalem Pharmaceuticals Co. Ltd. Approves Dividend for the Year 2018, Payable on 21 J..
CI
2019Jerusalem Pharmaceuticals Co. Ltd. Announces Audited Consolidated Earnings Results for ..
CI
More news
Financials (USD)
Sales 2021 46,2 M - -
Net income 2021 6,60 M - -
Net cash 2021 2,86 M - -
P/E ratio 2021 7,72x
Yield 2021 4,24%
Capitalization 62,1 M 62,1 M -
EV / Sales 2020 1,42x
EV / Sales 2021 1,04x
Nbr of Employees 540
Free-Float 37,1%
Chart JERUSALEM PHARMACEUTICALS CO. LTD.
Duration : Period :
Jerusalem Pharmaceuticals Co. Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Rami Waleed Mohammad Qutub Group General Manager
Mohammed Natour Group Chief Financial Officer
Mohammad Mahmoud Yousef Masrouji Chairman
Lina Fayeq Barakat Masrouji Deputy GM-Technical Affairs & Executive Director
Nidal Shawkat Ahmad Kamal Director